Michael Brines
Fondateur chez Warren Pharmaceuticals, Inc.
Postes actifs de Michael Brines
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Directeur Technique/Scientifique/R&D | 01/01/2001 | - |
| Fondateur | 01/01/2001 | - | |
Araim Pharmaceuticals, Inc.
 Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Directeur Technique/Scientifique/R&D | 01/01/2006 | - |
| Fondateur | 01/01/2006 | - |
Historique de carrière de Michael Brines
Anciens postes connus de Michael Brines
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Yale University | Directeur/Membre du Conseil | 01/01/1998 | 01/01/1998 |
Formation de Michael Brines
| The Rockefeller University | Doctorate Degree |
| University of Notre Dame | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Health Technology |
Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Health Technology |
- Bourse
- Insiders
- Michael Brines
- Expérience
